DVA (davita.com) Business Value to Revenue

Public company logo of DaVita HealthCare Partners (DVA)

DaVita Inc. (DVA) steady earnings from hemodialysis are constrained by strict Medicare government payment limits, as clearly demonstrated by the GURU.Markets service through the company's EV/Sales ratio, where the value has settled at 1714.71. Margin constraints resulting from personnel costs are offset by an aging population and the transition of patients to home treatment, which will serve as a key driver for future growth.

DVA davita.com: Enterprise Value-to-Revenue Ratio in the range 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for DaVita Corp (DVA)

- current quotes and average value forecast:
- business market valuation indicators:
Fundamental company valuation:DaVita, DVA
Manufactured product of DaVita Inc

This indicator determines the market value of the business relative to net debt per unit of generated revenue, eliminating the impact of credit load on the valuation. By analyzing the EV/Sales multiple of DaVita Inc. (DVA), an investor assesses the efficiency of converting revenue into total asset value without distortions from financial leverage. For DaVita Inc. (DVA), such a metric confirms its status as a mature operator of critical medical services within a strictly regulated government environment.

Direct competitors

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Company Value to Revenue SOLV|Encompass (EHC) - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Universal Health Services, Inc. (UHS)|Total Company Value-to-Revenue Ratio radnet.com|EV/Sales Multiple OPCH (optioncarehealth.com)|SGRY (Surgery Partners) - Enterprise Value to Sales Volume|PINC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio America's Best Contacts & Eyeglasses EYE|PGNY: EV/Sales Multiple|ARDT (Ardent Health Partners) - Enterprise Value-to-Revenue Ratio|SEM (selectmedical.com) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio ASTH|EV/Sales Multiple MD|Enterprise Value-to-Revenue Ratio USPH (US Physical Therapy Inc)|Enterprise Value-to-Revenue Ratio The Pennant Group, Inc. PNTG|Business Value to Revenue ORGO|NUTX - Enterprise Value-to-Revenue Ratio|AUNA - EV/Sales Multiple|SBC Medical Group Inc (SBC) - Enterprise Value-to-Revenue Ratio|EOLS: Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio chs.net|SKIN: Business Value to Revenue|EV/Sales Multiple MDWD|BTMD - Enterprise Value-to-Revenue Multiple|The Joint Chiropractic - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient DCGO (DocGo, Inc)|Total Company Value-to-Revenue Ratio PIII (p3hp.org)|GANX (Gain Therapeutics) - Company Value to Revenue Ratio|euda.com (EUDA) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Basel Medical|CLGN (CollPlant Biotechnologies) - EV/Sales Multiple|EV/Sales Multiple Cuprina Holdings Limited|Enterprise Value-to-Revenue Ratio concordmedical.com (CCM)|Enterprise Value-to-Revenue Ratio AMS (American Shared Hospital)|Enterprise Value-to-Revenue Ratio MEDIROM Corp MRM|EV/Sales Multiple avalon-globocare.com ALBT|DHAI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Longevity Health Holdings XAGE|NIVF (NewGenIvf Group Limited) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple